Transoral robotic surgery in Ireland: the beginning.

Autor: Keane E; St Vincent's University Hospital, Merrion Road, Dublin, Ireland. emmakeane@rcsi.ie.; ENT Department, Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin, Ireland. emmakeane@rcsi.ie., O'Riordan I; Mater Misericordiae Hospital, Eccles Street, Dublin, Ireland., Crotty T; Mater Misericordiae Hospital, Eccles Street, Dublin, Ireland., Hintze JM; St Vincent's University Hospital, Merrion Road, Dublin, Ireland., Shytaj E; St Vincent's University Hospital, Merrion Road, Dublin, Ireland., O'Duffy F; Mater Misericordiae Hospital, Eccles Street, Dublin, Ireland., O'Dwyer TP; St Vincent's University Hospital, Merrion Road, Dublin, Ireland., Moran T; St Vincent's University Hospital, Merrion Road, Dublin, Ireland.; Mater Misericordiae Hospital, Eccles Street, Dublin, Ireland.
Jazyk: angličtina
Zdroj: Irish journal of medical science [Ir J Med Sci] 2022 Feb; Vol. 191 (1), pp. 361-365. Date of Electronic Publication: 2021 Feb 09.
DOI: 10.1007/s11845-021-02539-w
Abstrakt: Background: Transoral robotic surgery (TORS) has shown promising results in the treatment of myriad head and neck pathologies but is now most commonly used in the investigation and management of oropharyngeal squamous cell carcinoma.
Aims: The aim of this study was to report our cases of the newly introduced TORS, particularly its role in identifying primary of unknown origin and the potential implications for patients. A literature review and our early experience should begin to debunk some of the criticisms of TORS including setup times and cost.
Methods: Prospective data was collected from all patients undergoing transoral robotic surgery including demographics, indication, histology results in primary of unknown origin and complications.
Results: We have performed 36 TORS procedures in total ranging from intermediate to major complex. Our complication rate is low, and this has improved with the passage of time. Haemorrhage rates remain at 5.6% (n = 2), and the average length of stay is 1 day. Successful identification of a primary tumour in cancer of unknown primary was 80% (n = 8).
Conclusions: We anticipate the integration of TORS into routine practice in the investigation and management of a number of ENT pathologies following robust clinical trials.
(© 2021. Royal Academy of Medicine in Ireland.)
Databáze: MEDLINE
Externí odkaz: